One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study (Q72888559)
Jump to navigation
Jump to search
scientific article published on 01 September 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study |
scientific article published on 01 September 1993 |
Statements
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study (English)
S E Rivkin
S Green
B Metch
W R Jewell
J J Costanzi
S J Altman
J P Minton
R M O'Bryan
1 September 1993